Рак вульвы: современные подходы к лечению

1. Sturgeon SR, Bronton LA, Devesa SS, Kurman RJ. In situ and invasive vulvar cancer incidence trends (1973 to 1987). Am J Obstet Gynecol 1992; 166:1482-5. 2. Ansink AC, Heintz AP. Epidemiology and etiology of squamous cell carcinoma of the vulva. Eur J Obstet Gynecol Reprod Biol 1993; 48:111-5. 3. Coulter J, Gleeson N. Local and regional recurrence of vulval cancer management dilemmas. Best Pract Res Clin Obstet Gynaecol 2003; 17:663-81. 4. Monaghan JM. The management of carcinoma of the vulva. In: Sheperd JH, Monaghan JM, editors. Clinical gynaecological oncology. 2nd ed. Oxford: Blackwell Scientific Publications; 1990. p.140-67. 5. Stang A, Streller B, Eisinger B, Jockel KH. Population-based incidence rates of malignant melanoma of the vulva in Germany. Gynecol Oncol 2005; 96:216-21. 6. Harting MS, Kim KB. Biochemotherapy in patients with advanced vulvovaginal mucosal melanoma. Melanoma Res 2004; 14:517-20. 7. Copeland LJ, Sneige N, Gershenson DM, McGuffee VB, Abdul-Karim F, Rutledge FN. Bartholin gland carcinoma. Obstet Gynecol 1986; 67:794-801. 8. Massad LS, De Gest K. Multimodality therapy for carcinoma of the Bartholin gland. Gynecol Oncol 1999; 75:305-7. 9. de Giorgi V, Salvini C, Massi D, Raspollini MR, Carli P. Vulvar basal cell carcinoma: retrospective study and review of literature. Gynecol Oncol 2005; 97:192-4. 10. Parker LP, Parker JR, Bodurka-Bevers D, et al. Paget’s disease of the vulva: pathology, pattern of involvement, and prognosis. Gynecol Oncol 2000; 77:183-9. 11. Ulutin HC, Zellars RC, Frassica D. Soft tissue sarcoma of the vulva: a clinical study. Int J Gynecol Cancer 2003; 13:528-31. 12. Neto AG, Deavers MT, Silva EG, Malpica A. Metastatic tumors of the vulva: clinicopathologic study of 66 cases. Am J Surg Pathol 2003; 27:799-804. 13. Flanagan CW, Parker JR, Mannel RS, Min KW, Kida M. Primary endodermal sinus tumor of the vulva: a case report and review of the literature. Gynecol Oncol 1997; 66:515-8. 14. Khunamornpong S, Siriaunkgul S, Suprasert P, Chitapanarux I. Yolk sac tumor of the vulva: a case report with long-term disease-free survival. Gynecol Oncol 2005; 97:238-42. 15. Piura B, Gemer O, Rabinovich A, Yanai-Inbar I. Primary breast carcinoma of the vulva: case report and review of literature. Eur J Gynaecol Oncol 2002; 23:21-4. 16. JapazeH, Van Dinh T, Woodruff JD. Verrucous carcinoma of the vulva: study of 24 cases. Obstet Gynecol 1982; 60:462-6. 17. Judson PL, Habermann EB, Baxter NN, Durham SB, Virnig BA. Trends in the incidence of invasive and in situ vulvar carcinoma. Obstet Gynecol 2006; 107:1018–22. 26. Pecorelli S. FIGO Committee on Gynecologic Oncology. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 2009; 105:103–4. 27. Shepherd JH. Cervical and vulva cancer: changes in FIGO definitions of staging. Br J Obstet Gynaecol 1996; 103:405-6. 28. Mutch DG. The new FIGO staging systems for cancers of the vulva, cervix, endometrium and sarcomas. Gynecol Oncol 2009; 115:325-328. 18. Beller U, Maissoneuve P, Benedet JL, et al. Carcinoma of the vulva. Int J Gynecol Obstet 2003; 83(suppl. 1):7-26. 19. Hacker NF, Berek JS, Lagasse LD, Leuchter RS, Moore JG. Management of regional lymph nodes and their prognostic influence in vulvar cancer. Obstet Gynecol 1983; 61:408-12. 20. Podratz KC, Symmonds RE, Taylor WF, Williams TJ. Carcinoma of the vulva: analysis of treatment and survival. Obstet Gynecol 1983; 61:63-74. 21. Homesley HD, Bundy BN, Sedlis A, et al. Prognostic factors for groin node metastasis in squamous cell carcinoma of the vulva (a Gynecologic Oncology Group Study). Gynecol Oncol 1993; 49:279-83. 22. Gadducci A, Prato B, Fanucchi A, Bonuccelli A, Cristofani R, Facchini V. Disease-free survival in patients with squamous cell carcinoma of the vulva treated with radical vulvectomy and bilateral inguinal-femoral lymphadenectomy: analysis of prognostic variables. Cancer J 1993; 6:269-73. 23. Creasman WT, Phillips JL, Menck HR. The National Cancer Data Base report on early stage invasive vulvar carcinoma. Cancer 1997; 80:505-13. 24. Maggino T, Landoni F, Sartori E, et al. Patterns of recurrence in patients with squamous cell carcinoma of the vulva. A multicenter CTF study. Cancer 2000; 89:116-22. 25. Hacker NF, Van der Velden J. Conservative management of early vulvar cancer. Cancer 1993; 71:1673-7. 29. Way S. The anatomy of the lymphatic drainage of the vulva and its influence on radical operation for carcinoma. Ann R Coll Surg Engl 1948; 3:187-209. 30. Way S. Carcinoma of the vulva. Am J Obstet Gynecol 1960; 79:692-7. 31. Hacker NF. Vulvar cancer. In: Berek JS, Hacker NF, editors. Practical Gynecologic Oncology. 3rd ed. Baltimore: Williams and Wilkins; 2000. p. 553-96. 32. Christophersen W, Herbert J, Buchsbaum MD, Voet R, Litschitz S. Radical vulvectomy and bilateral groin lymphadenectomy utilizing separate groin incisions: report of a case with recurrence in the intervening skin bridge. Gynecol Oncol 1985; 21:247-51. 33. Burger MPM, Hollema H, Bouma J. The side of groin node metastases in unilateral vulvar carcinoma. Int J Gynecol Cancer 1996; 6:318-2322. 34. Iversen T, Aas M. Lymph drainage from the vulva. Gynecol Oncol 1983; 16:179–89. 35. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1977; 39:456–66. 36. Morton DL, Thompson JF, Essner R, Elashoff R, Stern SL, Nieweg OE, et al. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg 1999; 230:453–63 discussion 63–5. 37. Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, et al. Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. Lancet Oncol 2006; 7:983–90. 38. Dargent D, Martin X, Mathevet P. Laparoscopic assessment of the sentinel lymph node in early stage cervical cancer. Gynecol Oncol 2000; 79:411–5. 39. Hauspy J, Beiner M, Harley I, Ehrlich L, Rasty G, Covens A. Sentinel lymph nodes in early stage cervical cancer. Gynecol Oncol 2007; 105:285–90. 40. De Cicco C, Sideri M, Bartolomei M, Grana C, Cremonesi M, Fiorenza M, et al. Sentinel node biopsy in early vulvar cancer. Br J Cancer 2000; 82:295–9. 41. de Hullu JA, Hollema H, Piers DA, Verheijen RH, van Diest PJ, Mourits MJ, et al. Sentinel lymph node procedure is highly accurate in squamous cell carcinoma of the vulva. J Clin Oncol 2000; 18:2811–6. 42. Levenback C, Coleman RL, Burke TW, Bodurka-Bevers D, Wolf JK, Gershenson DM. Intraoperative lymphatic mapping and sentinel node identification with blue dye in patients with vulvar cancer. Gynecol Oncol 2001; 83:276–81. 43. Moore DH, Thomas GM, Montana GS, Saxer A, Gallup DG, Olt G. Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the Gynecologic Oncology Group. Int J Radiat Oncol Biol Phys 1998; 42:79–85. 44. Hauspy J, Beiner M, Harley I, Ehrlich L, Rasty G, Covens A. Sentinel lymph node in vulvar cancer. Cancer 2007; 110:1015–23. 45. Merisio C, Berretta R, Gualdi M, Pultrone DC, Anfuso S, Agnese G, et al. Radioguided sentinel lymph node detection in vulvar cancer. Int J Gynecol Cancer 2005; 15:493–7. 46. Rob L, Robova H, Pluta M, Strnad P, Kacirek J, Skapa P, et al. Further data on sentinel lymph node mapping in vulvar cancer by blue dye and radiocolloid Tc99. Int J Gynecol Cancer 2007; 17:147–53. 47. Nyberg RH, Iivonen M, Parkkinen J, Kuoppala T, Maenpaa JU. Sentinel node and vulvar cancer: a series of 47 patients. Acta Obstet Gynecol Scand 2007; 86:615–9. 48. Puig-Tintore LM, Ordi J, Vidal-Sicart S, Lejarcegui JA, Torne A, Pahisa J, et al. Further data on the usefulness of sentinel lymph node identification and ultrastaging in vulvar squamous cell carcinoma. Gynecol Oncol 2003; 88:29–34. 49. Oonk MH, Hollema H, de Hullu JA, van der Zee AG. Prediction of lymph node metastases in vulvar cancer: a review. Int J Gynecol Cancer 2006; 16:963–71. 50. Van der Zee AG, Oonk MH, De Hullu JA, Ansink AC, Vergote I, Verheijen RH, et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol 2008; 26:884–9. 51. de Hullu JA, Oonk MH, Ansink AC, Hollema H, Jager PL, van der Zee AG. Pitfalls in the sentinel lymph node procedure in vulvar cancer. Gynecol Oncol 2004; 94:10–5. 52. Fons G, ter Rahe B, Sloof G, de Hullu J, van der Velden J. Failure in the detection of the sentinel lymph node with a combined technique of radioactive tracer and blue dye in a patient with cancer of the vulva and a single positive lymph node. Gynecol Oncol 2004; 92:981–4. 53. Louis-Sylvestre C, Evangelista E, Leonard F, Itti E, Meignan M, Paniel BJ. Sentinel node localization should be interpreted with caution in midline vulvar cancer. Gynecol Oncol 2005; 97:151–4. 54. Martinez-Palones JM, Perez-Benavente MA, Gil-Moreno A, Diaz-Feijoo B, Roca I, Garcia-Jimenez A, et al. Comparison of recurrence after vulvectomy and lymphadenectomy with and without sentinel node biopsy in early stage vulvar cancer. Gynecol Oncol 2006; 103:865 70. 55. Raspagliesi F, Ditto A, Fontanelli R, Maccauro M, Carcangiu ML, Parazzini F, et al. False-negative sentinel node in patients with vulvar cancer: a case study. Int J Gynecol Cancer 2003; 13:361–3. 56. Stehman FB, Look KY. Carcinoma of the vulva. Obstet Gynecol 2006;107:719-33. 57. van Doorn HC, Ansink A, Verhaar-Langereis M, Stalpers L. Neoadjuvant chemoradiation for advanced primary vulvar cancer. Cochrane Database Syst Rev. 2006; 19:3. 58. Hopkins MP, Reid GC:,MorIey GW. The surgical management of recurrent squamous cell carcinoma of the vulva. Obstet Gynecol 1990; 75:1001-5. 59. de Hullu JA, Hollema H, Lolkema S, Boezen M, Bonstra H, Burger MP, et al. Vulvar carcinoma: the price of less radical surgery. Cancer 2002; 95:2331-8. 60. Tilmans AS, Sutton GP, Look KY, Stehman FB, Ehrlich CE, Homback NB. Recurrent squamous carcinoma of the vulva. Am J Obstet Gynecol 1992; 167:1383-9. 61. Sznurkowski J, Emerich J. Characteristic features of recurrences of squamous cell carcinoma of the vulva. Ginekol Pol 2010; 81:12-9. 62. Piura B, Masotina A, Murdoch J, et al. Recurrent squamous cell carcinoma of the vulva: a study of 73 cases. Gynecol Oncol 1993; 48:189-95. 63. Podratz KC, Symmonds RE, Taylor WF et al. Carcinoma of the vulva: analysis of treatment and survival. Obstet 1983; 6:63. 64. Tilmans AS, Sutton GP, Look KY, et al. Recurrent squamous carcinoma of the vulva. Am J Obstet Gynecol 1992; 167:1383. 65. Cavanagh D, Hoffman MS. Controversies in the management of vulvar carcinoma. Br J Obstet Gynaecol 1996; 103:293-300. 66. Helm CW, Hatch K, Austin JM, Partridge EE, Soong SJ, Elder JE, et al. A matched comparison of single and triple incision techniques for the surgical treatment of carcinoma of the vulva. Gynecol Oncol 1992; 46:150-6. 67.. Lin JY, DuBeshter B, Angel C, Dvoretsky PM. Morbidity and recurrence with modifications of radical vulvectomy and groin dissections. Gynecol Oncol 1992; 47:80-6. 68. Stehman FB, Bundy BN, Ball H, Clarke-Pearson Dl. Sites of failure and times to failure in carcinoma of the vulva treated conservatively: Gynecologic Oncology Group study. Am J Obstet Gynecol 1996; 174:1128-32. 69. Woolderink JM, Bock GH, Hullu JA, et al. Patterns of frequency of recurrences of squamous cell carcinoma of the vulva. Gynecologic Oncology 2006; 103:293-299. 70. Rowley KC, Gallion HH, Donaldson ES, van Nagell JR, Higgins RV, Powell DE, et al. Prognostic factors in early vulvar cancer. Gynecol Oncol 1988; 31:43–9. 71. Heaps JM, Fu YS, Montz FJ, Hacker NF, Berek JS. Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva. Gynecol Oncol 1990; 38:309-14. 72. Rouzier R, Haddad B, Plantier F, Dubois P, Pelisse M, Paniel BJ. Local relapse in patients treated for squamous cell vulvar carcinoma: incidence and prognostic value. Obstet Gynecol 2002; 100:1159-67. 73. Preti M, Ronco G, Ghiringhello B, Micheletti L. Recurrent squamous cell carcinoma of the vulva: clinicopathologic determinants identifying low risk patients. Cancer 2000; 88:1869-1876. 74. van der Velden J, Schilthuis MS, Hyde SE, Ten Kate FJ, Burger MP. Squamous cell cancer of the vulva with occult lymph node metastases in the groin: the impact of surgical technique on recurrence pattern and survival. Int J Gynecol Cancer 2004; 14:633-8. 75. Miller B, Morris M, Levenback C., et al. Pelvic exenteration for primary and recurrent vulvar cancer. Gynecol Oncol 1995; 58:202-205. 76. Piura B, Masogina A, Murdoch J, et al. Recurrent squamous cell carcinoma of the vulva: a study of 73 cases. Gynecol Oncol 1993; 48:189–195. 77. Hopkins M, Reid G, Morley G. The surgical management of recurrent squamous cell carcinoma of the vulva. Obstet Gynecol 1990; 75:1001–1005. 78. Chakolva G, Karagiozov A. The surgical management of recurrent carcinoma of the vulva. Eur J Gynaec Oncol 1993: 14:318–321. 79. Salom EM, Penalver M. Recurrent vulvar cancer. Current Treatment Options in Oncology 2002; 3:143-153. 80. Shimm DS, Fuller AF, Orlow EL, Dosoretz DE, Aristizabal SA. Prognostic variables in the treatment of squamous cell carcinoma of the vulva. Gynecol Oncol 1986; 24:343-58. 81. Tewari K, Cappuccini F, Syed AM, et al. Interstitial brachytherapy in the treatment of advanced and recurrent vulvar cancer. American Journal of Obstetrics and Gynecology 1999; 181:91-98. 82. Hoffman M, Greenberg S, Greenberg H, et al. Interstitial radiotherapy for the treatment of advanced or recurrent vulvar and distant vaginal malignancy. American Journal of Obstetrics and Gyecology 1990; 162:1278-1282. 83. Homesley HD, Bundy BN, Sedlis A, Adcock L. Radiation therapy versus pelvic node resection for carcinoma of the vulva with positive groin nodes. Obstet Gynecol 1986; 68:733-40. 84. Sedlis A et al. Positive groin lymph nodes in superficial squamous cell vulvar cancer. A Gynecologic Oncology Group study. Am J Obstet Gynecol 1987; 156:1159-64. 85. Homesley HD et al. Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival (a Gynecologic Oncology Group study). Am J Obstet Gynecol 1991; 164:997-1004. 86. Stehman FB, Bundy BN, Dvoretsky PM, Creasman WT. Early stage I carcinoma of the vulva treated with ipsilateral superficial inguinal lymphadenectomy and modified radical hemivulvectomy: a prospective study of the Gynecologic Oncology Group. Obstet Gynecol 1992; 79:490-7. 87. Burke TW, Levenback C, Coleman RL, Morris M, Silva EG, Gerschenson DM. Surgical therapy of T1 and T2 vulvar carcinoma: further experience with radical wide excision and selective inguinal lymphadenectomy. Gynecol Oncol 1995; 57:215-20. 88. Burger MPM, Hollema H, Emanuels AG, Krans M, Pras E, Bouma J. The importance of the groin node status for the survival of T1 and T2 vulval carcinoma patients. Gynecol Oncol 1995; 57:327-34. 89. Prempree T, Amornmarn R. Radiation treatment of recurrent carcinoma of the vulva. Cancer 1984; 54:1943–1949.